Regulus Therapeutics
RGLS
#7021
Rank
$0.56 B
Marketcap
$8.16
Share price
0.00%
Change (1 day)
436.84%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: $0.56 Billion USD

On August 27, 2025 Regulus Therapeutics had a market cap of $0.56 Billion USD. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025$0.56 B460.08%
2024$0.10 B289.68%
2023$25.88 M12.2%
2022$23.07 M-49.82%
2021$45.98 M-46.37%
2020$85.73 M358.29%
2019$18.7 M127.96%
2018$8.2 M-92.41%
2017$0.10 B-9.21%
2016$0.11 B-74.07%
2015$0.45 B-41.5%
2014$0.78 B154.23%
2013$0.30 B36.8%
2012$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
$114.25 B 20,123.91%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$26.39 B 4,571.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$112.06 B 19,736.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$287.63 B 50,814.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$104.28 B 18,359.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
$0.18 B-68.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
$2.97 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$44.66 B 7,805.55%๐Ÿ‡บ๐Ÿ‡ธ USA